Cite
HARVARD Citation
Klein, N. et al. (2020). Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study. Journal of the Pediatric Infectious Diseases Society. pp. 194-201. [Online].